NCT03927300

Brief Summary

The investigators proposed to conduct a retrospective study to evaluate the impact of the implementation of apTeleCare software on the management of dialysis patients at home in terms of the number and duration of hospitalizations. For this purpose, the investigators will compare patients' data over a 2-year interval before the introduction of Telemonitoring (January 2012 and December 2013 inclusive - Group 1) with patients data who have benefited from this application (between August 2016 and July 2018).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 12, 2019

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 25, 2019

Completed
3 months until next milestone

Study Start

First participant enrolled

July 17, 2019

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 17, 2019

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 11, 2019

Completed
Last Updated

March 10, 2020

Status Verified

March 1, 2020

Enrollment Period

Same day

First QC Date

April 12, 2019

Last Update Submit

March 9, 2020

Conditions

Keywords

Home Peritoneal Dialysis

Outcome Measures

Primary Outcomes (2)

  • Cumulative duration (on retrospective two years of follow-up) of the unscheduled hospitalizations between the two patient groups.

    up to two years.

  • Cumulative duration (on retrospective two years of follow-up) of the scheduled hospitalizations between the two patient groups.

    up to two years.

Secondary Outcomes (6)

  • Total length of hospitalisation

    For both groups. Every two months (follow-up visit) on a retrospective period of two years, the outcome 2 will be measured. The study duration will be of 5 months

  • Number of events of cardiovascular complications

    For both groups. Every two months (follow-up visit) on a retrospective period of two years. The study duration will be of 5 months

  • Mortality rate

    For both groups. At the end of this retrospective study (Study Period of 5 months).

  • Rate of peritoneal infections

    For both groups. At the end of this retrospective study.(Study Period of 5 months).

  • Number of patient exit technique except death

    For both groups. At the end of this retrospective study. (Study Period of 5 months).

  • +1 more secondary outcomes

Study Arms (2)

Patients without Telemonitoring with ApTelecare Software

Patients with implementation of Telemonitoring with ApTelecare

Device: Telemonitoring Software

Interventions

Recovery of retrospective data in dialysis patients follow or not follow by a telemonitoring application.

Patients with implementation of Telemonitoring with ApTelecare

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with a chronic renal failure who are take care in the dialysis unit. These patients are their peritoneal dialysis at home and use or not the telemonitoring software "ApTelecare".

You may qualify if:

  • Adult patients (≥ 18 years) with no age limit;
  • Patients receiving peritoneal dialysis on the investigation center between 2012 and 2014 (Group1) and between 2016 and 2018 (Group 2);
  • Patient information in this retrospective study;

You may not qualify if:

  • Patients who have started a peritoneal dialysis program before the periods of investigation;
  • Patients who have been equipped with apTeleCare during the dialysis program;
  • Subject under guardianship, curators or safeguard of justice;
  • Patient not affiliated to a French social protection;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Matthieu Merlot

Montpellier, 34184, France

Location

MeSH Terms

Conditions

Kidney Failure, Chronic

Condition Hierarchy (Ancestors)

Renal Insufficiency, ChronicRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
1 Day
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 12, 2019

First Posted

April 25, 2019

Study Start

July 17, 2019

Primary Completion

July 17, 2019

Study Completion

December 11, 2019

Last Updated

March 10, 2020

Record last verified: 2020-03

Locations